GlobeImmune Inc. announced that Timothy C. Rodell has resigned his positions as the company's Chief Executive Officer and President but remains on the Board of Directors; C. Jeffrey Dekker has been appointed as the company's President, Secretary and Treasurer and been named to the company's Board of Directors; J. William Freytag, Augustine J. Lawlor, Dan J. Mitchell and S. Edward Torres have resigned from the company's Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5 | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |
- Stock Market
- Equities
- GBIM Stock
- News GlobeImmune, Inc.
- GlobeImmune Inc. Announces Management and Board Changes